{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:32:26Z","timestamp":1791919946839,"version":"4.3.4"},"reference-count":24,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,22]],"date-time":"2022-06-22T00:00:00Z","timestamp":1655856000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007112","name":"University of Cape Town","doi-asserted-by":"publisher","award":["1U01AI152153"],"award-info":[{"award-number":["1U01AI152153"]}],"id":[{"id":"10.13039\/501100007112","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["kireports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International Reports"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.ekir.2022.06.013","type":"journal-article","created":{"date-parts":[[2022,7,6]],"date-time":"2022-07-06T13:59:09Z","timestamp":1657115949000},"page":"2039-2046","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Retrospective Review of ART Regimens in HIV-Positive to HIV-Positive Kidney Transplant Recipients"],"prefix":"10.1016","volume":"7","author":[{"given":"Zunaid","family":"Barday","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn","family":"Manning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Freercks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurie","family":"Bertels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9917-223X","authenticated-orcid":false,"given":"Nicola","family":"Wearne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elmi","family":"Muller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ekir.2022.06.013_bib1","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1056\/NEJMc0900837","article-title":"Renal transplantation between HIV-positive donors and recipients","volume":"362","author":"Muller","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ekir.2022.06.013_bib2","first-page":"185","article-title":"South African renal registry annual report 2018","volume":"23","author":"Davids","year":"2020","journal-title":"Afr J Nephrol"},{"key":"10.1016\/j.ekir.2022.06.013_bib3","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1056\/NEJMoa1408896","article-title":"HIV-positive\u2013to\u2013HIV-positive kidney transplantation\u2014results at 3 to 5 years","volume":"372","author":"Muller","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ekir.2022.06.013_bib4","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1056\/NEJMc1903013","article-title":"Longer-term outcomes of HIV-positive\u2013to\u2013HIV-positive renal transplantation","volume":"381","author":"Selhorst","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ekir.2022.06.013_bib5","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1111\/ajt.16886","article-title":"HOPE in action: a prospective multicenter pilot study of liver transplantation from donors with HIV to recipients with HIV","volume":"22","author":"Durand","year":"2022","journal-title":"Am J Transplant"},{"key":"10.1016\/j.ekir.2022.06.013_bib6","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/j.1523-1755.2004.00772.x","article-title":"Antiretroviral and immunosuppressive drug-drug interactions: an update","volume":"66","author":"Izzedine","year":"2004","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2022.06.013_bib7","doi-asserted-by":"crossref","first-page":"3114","DOI":"10.1111\/ajt.14419","article-title":"Impact of protease inhibitor\u2013based anti-retroviral therapy on outcomes for HIV+ kidney transplant recipients","volume":"17","author":"Sawinski","year":"2017","journal-title":"Am J Transplant"},{"key":"10.1016\/j.ekir.2022.06.013_bib8","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13534","article-title":"Higher rates of rejection in HIV-infected kidney transplant recipients on ritonavir-boosted protease inhibitors: 3-year follow-up study","volume":"33","author":"Rollins","year":"2019","journal-title":"Clin Transplant"},{"key":"10.1016\/j.ekir.2022.06.013_bib9","doi-asserted-by":"crossref","DOI":"10.1111\/tid.12992","article-title":"Impact of antiretroviral regimen on renal transplant outcomes in HIV-infected recipients","volume":"20","author":"Sparkes","year":"2018","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.ekir.2022.06.013_bib10","doi-asserted-by":"crossref","first-page":"707","DOI":"10.2165\/00002018-200225100-00003","article-title":"Drug interactions with tacrolimus","volume":"25","author":"van Gelder","year":"2002","journal-title":"Drug Saf"},{"key":"10.1016\/j.ekir.2022.06.013_bib11","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1097\/TP.0b013e3182734651","article-title":"Pretransplantation pharmacokinetic curves of tacrolimus in HIV-infected patients on ritonavir-containing cART: a pilot study","volume":"95","author":"van Maarseveen","year":"2013","journal-title":"Transplantation"},{"key":"10.1016\/j.ekir.2022.06.013_bib12","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1002\/bdd.1860","article-title":"Changes in clearance, volume and bioavailability of immunosuppressants when given with HAART in HIV-1 infected liver and kidney transplant recipients","volume":"34","author":"Frassetto","year":"2013","journal-title":"Biopharm Drug Dispos"},{"key":"10.1016\/j.ekir.2022.06.013_bib13","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1086\/518976","article-title":"A\u00a0high incidence of lactic acidosis and symptomatic hyperlactatemia in women receiving highly active antiretroviral therapy in Soweto, South Africa","volume":"45","author":"Bolhaar","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ekir.2022.06.013_bib14","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1177\/0091270004269142","article-title":"Induction of CYP3A4 by efavirenz in primary human hepatocytes: comparison with rifampin and phenobarbital","volume":"44","author":"Hariparsad","year":"2004","journal-title":"J\u00a0Clin Pharmacol"},{"key":"10.1016\/j.ekir.2022.06.013_bib15","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1097\/TP.0000000000002366","article-title":"2018 reference guide to the Banff classification of renal allograft pathology","volume":"102","author":"Roufosse","year":"2018","journal-title":"Transplantation"},{"key":"10.1016\/j.ekir.2022.06.013_bib16","first-page":"159","article-title":"CYP3A5 polymorphisms and their effects on tacrolimus exposure in an ethnically diverse South African renal transplant population","volume":"110","author":"Muller","year":"2020","journal-title":"S\u00a0Afr Med J"},{"key":"10.1016\/j.ekir.2022.06.013_bib17","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1681\/ASN.2012080857","article-title":"Tenofovir effect on the kidneys of HIV-infected patients: a double-edged sword?","volume":"24","author":"Tourret","year":"2013","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2022.06.013_bib18","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1097\/QAI.0000000000001344","article-title":"Brief report: long-term (96-week) efficacy and safety after switching from tenofovir disoproxil fumarate to tenofovir alafenamide in HIV-infected, virologically suppressed adults","volume":"75","author":"Raffi","year":"2017","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"key":"10.1016\/j.ekir.2022.06.013_bib19","first-page":"492","article-title":"Treatment-limiting renal tubulopathy in patients treated with tenofovir disoproxil fumarate","volume":"74","author":"Hamzah","year":"2017","journal-title":"J\u00a0Infect"},{"key":"10.1016\/j.ekir.2022.06.013_bib20","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1097\/QAD.0000000000000103","article-title":"Antiretrovirals and the kidney in current clinical practice: renal pharmacokinetics, alterations of renal function and renal toxicity","volume":"28","author":"Yombi","year":"2014","journal-title":"AIDS"},{"key":"10.1016\/j.ekir.2022.06.013_bib21","doi-asserted-by":"crossref","first-page":"20","DOI":"10.2174\/157488408783329913","article-title":"AZT: an old drug with new perspectives","volume":"3","author":"D\u2019Andrea","year":"2008","journal-title":"Curr Clin Pharmacol"},{"key":"10.1016\/j.ekir.2022.06.013_bib22","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1097\/TP.0000000000003485","article-title":"Kidney transplantation in HIV positive patients: current practice and management strategies","volume":"105","author":"Muller","year":"2020","journal-title":"Transplantation"},{"key":"10.1016\/j.ekir.2022.06.013_bib23","doi-asserted-by":"crossref","DOI":"10.1111\/ajt.14479","article-title":"Strengths and weaknesses of using SRTR data to shape the management of the HIV-infected kidney transplant recipient","volume":"17","author":"Stock","year":"2017","journal-title":"Am J Transplant"},{"key":"10.1016\/j.ekir.2022.06.013_bib24","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1177\/0956462416651528","article-title":"Integrase strand transferase inhibitors: the preferred antiretroviral regimen in HIV-positive renal transplantation","volume":"28","author":"Azar","year":"2017","journal-title":"Int J STD AIDS"}],"container-title":["Kidney International Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S246802492201470X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S246802492201470X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T03:40:39Z","timestamp":1762832439000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S246802492201470X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":24,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S246802492201470X"],"URL":"https:\/\/doi.org\/10.1016\/j.ekir.2022.06.013","relation":{},"ISSN":["2468-0249"],"issn-type":[{"value":"2468-0249","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Retrospective Review of ART Regimens in HIV-Positive to HIV-Positive Kidney Transplant Recipients","name":"articletitle","label":"Article Title"},{"value":"Kidney International Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ekir.2022.06.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 International Society of Nephrology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}